Work

Clinical Application of Actinium-225 Radiopharmaceuticals in Targeted Alpha Therapy

Year: 2023

Type: article

Abstract: Among the vast variety of radionuclides available, a handful of them possess proper features for targeted alpha therapy (TAT). TAT holds the promise of exceeding the effectiveness of conventional radiotherapy methods. Actinium-225 is considered to be an outstanding isotope for TAT in the management of cancer due to its half-life, which enables sustained delivery at the tumor site. This review covers the clinical applications of actinium-225 radiopharmaceuticals.

Source: DOAJ (DOAJ: Directory of Open Access Journals)

Authors: Solmaz Mojarad-Jabali, Sajjad Molavipordanjani

Institution: Mazandaran University of Medical Sciences

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7164241024

FWCI:

Cites:

Cited by:

Related to: 10